The Almac Group is an established contract development and manufacturing organization (CDMO) providing an extensive range of integrated services across the drug development lifecycle. From early-stage biomarker discovery and API manufacture to clinical trial supply and commercial-scale production, Almac delivers quality-driven solutions to global pharmaceutical and biotech partners.